The results showed that IGF2BP2 maintained independence when predicting the OS of patients with pancreatic cancer (HR = 3.895, 95% CI = 1.895–4.634, P < 0.001; Additional file 3: Table S3). The gene discussed is IGF2BP2; the disease is pancreatic neoplasm.